Ledig stilling

Helse Sør-øst RHF

Unit Leader, "Systems Cancer Biomedicine"

Offentlig forvaltning

The Institute for Cancer Research (ICR), organized as part of the Division for Cancer Medicine, conducts cutting-edge cancer research ranging from basic biology to translational and clinical research. It is Norway’s leading cancer research institute with a strong international standing. ICR, located close to the new Radium Hospital/Cancer Clinic, has currently 390 employees organized in 25 research groups. Within ICR, Department of Molecular Oncology’s main research programs are devoted to colorectal cancer and prostate cancer. The department has a longstanding project portfolio also on other solid tumour types. Their expertise in biomedical research spans several disciplines from cell biology to translational research, including also active clinical research collaborations, and there is a broad range of advanced technologies established in-lab. Cancer Systems Biomedicine is a prioritized research area within the ICR and Department of Molecular Oncology (strategy document)

We are seeking an experienced scientist to join the Department of Molecular Oncology as Unit Leader in Systems Cancer Biomedicine, focusing on computational cancer biology and contributing to developing the computational biology infrastructure. This role involves a 50 % commitment to leading independent research projects and another 50 % to overseeing e-infrastructure, analysis pipelines, data management, and large-scale computation within the Department and contributing to the systems cancer biomedicine network at the Institute. Start up date after agreement.

Oslo University Hospital is a workplace with great diversity. We believe that this is absolutely essential for accomplishing the tasks required of us. Therefore, we want this diversity to be reflected among the applicants for our positions and encourage everyone to apply, regardless of who you are or what background you have.

Kvalifikasjoner:

Formal requirements:

  • The candidate must have a PhD in cancer bioinformatics, and formal education (minimum master level) in informatics and/or cancer biology/biomedicine.
  • The candidate should have proven academic experience in cancer research, including biology, genomics and informatics. This experience should encompass research on common solid tumours.
  • The candidate should have advanced hands-on expertise in handling high-throughput DNA and RNA-sequencing data, databases, and scripting/programming (e.g. Unix, Python, R).
  • It is important that the candidate is familiar with Norwegian national e-infrastructure for academic research institutions.
  • The candidate should have demonstrated experience in training and supervising informatics personnel.

Personlige egenskaper:

  • Good written and oral communication skills.
  • Strong collaborative skills and a proactive approach to fostering a productive work environment.
  • High motivation and commitment to contributing to complex transdisciplinary projects.
  • Ability to develop analytical workflows with existing software.
  • Ability to develop new software/algorithms that are logical and intuitive for users.

Vi tilbyr:

  • Participation in a strong scientific environment focused on cancer genomics and translational research.
  • A supportive and satisfactory work environment as evidenced by top employee satisfaction scores over recent years.
  • Competitive salary in line with Norwegian standards and according to qualifications (expertise and documented experience).
  • Membership in the pension system and insurance and an inclusive work-life culture.

 

Application Process
Submit your application electronically through the Webcruiter portal (ID: 4869996819), as only applications submitted through this portal will be considered. Attach certificates and diplomas to the application. Please note that parts of the submission portal are available in Norwegian. If you require assistance with your application due to the Norwegian language sections, or if you have other enquiries, please contact us.